SCHEMBL8957288

SCHEMBL8957288

CC(C)(C)OC(=O)CN(CCN(CC(=O)OC(C)(C)C)CC(Cc1ccc(OCC(=O)NCCCCCCCCCCC(=O)O)cc1)N(CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C)CC(=O)OC(C)(C)C

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 2/20 0.44
ITGA2B P08514 2/20 0.44
EPOR P19235 2/20 0.37
HDAC8 Q9BY41 3/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP3A4 P08684 1/20 0.35
KDM4E B2RXH2 1/20 0.35
TSHR P16473 1/20 0.35
RECQL P46063 1/20 0.35
PTPN1 P18031 1/20 0.35
PSMB1 P20618 2/20 0.35
PSMB5 P28074 2/20 0.35
PSMB2 P49721 2/20 0.35
NPSR1 Q6W5P4 1/20 0.34
HTT P42858 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HDAC3 O15379 1/20 0.34
HDAC4 P56524 1/20 0.34
HDAC1 Q13547 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8957276 0.96 ITGB3 (0.46) ITGB3ITGA2BEPORHDAC8KDM4E
SCHEMBL8099592 0.85 SMN1; SMN2 (0.40) ITGB3ITGA2BHDAC8TSHRPTPN1
SCHEMBL7516386 0.83 PTPN1 (0.41) ITGB3ITGA2BHDAC8PTPN1
SCHEMBL8957358 0.81 ITGB3 (0.45) ITGB3ITGA2BEPORCYP1A2CYP2D6
SCHEMBL6047694 0.80 EPOR (0.40) ITGB3ITGA2BEPOR
SCHEMBL6047708 0.80 EPOR (0.40) ITGB3ITGA2BEPOR
SCHEMBL21852438 0.80 MAOB (0.38) SMN1; SMN2
SCHEMBL15044629 0.79 ACACB (0.38) KDM4EHTTSMN1; SMN2
SCHEMBL92706 0.79 ACACB (0.38) KDM4EHTTSMN1; SMN2
SCHEMBL8902337 0.77 NR1D1 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5482700-A Substituted polyamino, polycarboxy complexing agent dimers for MRI and X-ray contrast SCHERING AKTIENGESELLSCHAFT (DE) 1996-01-09 US disclosed